Articles related to Infectious Diseases

A multicenter cross-sectional study associated symptomatic uncomplicated diverticular disease with reduced microbial diversity and distinct taxonomic and predicted functional patterns. The findings remain hypothesis-generating and require validation in larger, longitudinal cohorts.

The FDA approved Moderna’s mFLUSIVA, the first mRNA influenza vaccine, for adults aged 50 and older. Availability is expected during the 2026–2027 respiratory virus season, with confirmatory evidence pending for adults 65 and older.

A 16-year-old girl presented with acute aphasia and right-sided weakness consistent with a large-vessel stroke syndrome. Neuroimaging confirmed left middle cerebral artery occlusion, but the underlying etiology was not immediately apparent.

U.S. News expanded its 2026-2027 hospital rankings with new regional specialty evaluations in cancer and cardiovascular care while increasing recognition for regional hospitals. Rankings continued to emphasize risk-adjusted mortality, preventable complications, patient experience, and objective outcomes measures.

Fluvoxamine reduced fatigue and improved quality-of-life measures in adults with long COVID in a randomized placebo-controlled trial. The findings provide evidence for a potential therapy, although further research is needed to define optimal patient selection and treatment strategies.

More than 4,100 laboratory-confirmed cyclospora infections have been reported across 41 states during a larger-than-usual US outbreak. Investigators continue to search for the source, and no food product has been definitively confirmed as responsible.